You are here
INTEZYNE TECHNOLOGIES, INC.
UEI: N/A
# of Employees: 7
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Micellar Daunorubicin for the Treatment of Bone Cancer
Amount: $156,868.00DESCRIPTION (provided by applicant): According to the American Cancer Society, half of all men and one-third of all women in the United States will develop cancer in their lifetime. While chemotherapy ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
HHSN261201400018C;EPOTHILONE D FORMULATED IN POLYMER MICELLE NANOPARTICLES; POP: 09/17/2014 TO 05/16/2016
Amount: $944,978.00This project aims to optimize the lead formulation of epothilone D encapsulated in a stable nanoparticle for the treatment of solid malignancies, and assist in providing for the GMP manufacturing and ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Targeted Polymer Micelles for Treatment of Metastatic Melanoma
Amount: $139,587.00DESCRIPTION (provided by applicant): According to the American Cancer Society, half of all men and one-third of all women in the United States will develop cancer in their lifetime. While chemotherapy ...
STTRPhase I2013Department of Health and Human Services National Institutes of Health -
IGF::OT::IGF OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)
Amount: $187,222.00This project aims to develop a stabilized epothilone B (Epo B)-loaded micelle for the intravenous delivery of Epo B to solid tumors. The data should demonstrate that Epo B is encapsulated within the m ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health